Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery
Authors:
- Daniela CardinaleDCDaniela Cardinale
- Maria T. SandriMSMaria T. Sandri
- Alessandro ColomboACAlessandro Colombo
- Michela SalvaticiMSMichela Salvatici
- Ines TedeschiITInes Tedeschi
- Giulia BacchianiGBGiulia Bacchiani
- Marta BeggiatoMBMarta Beggiato
- Carlo A. MeroniCMCarlo A. Meroni
- Maurizio CivelliMCMaurizio Civelli
- Giuseppina LamantiaGLGiuseppina Lamantia
- Nicola ColomboNCNicola Colombo
- Fabrizio VegliaFVFabrizio Veglia
- 1 August 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 264 (2) , 244-251
Abstract
We performed a prospective, randomized clinical study to assess whether prophylactic treatment with metoprolol or losartan, initiated soon after lung cancer surgery in patients with elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, reduces the incidence of postoperative atrial fibrillation. Postoperative atrial fibrillation is a well recognized complication after lung cancer surgery, with an incidence as high as 30%. Perioperative increase of NT-proBNP has been demonstrated to be a strong independent predictor of postoperative atrial fibrillation in this setting. NT-proBNP concentration was measured 24 hours before surgery and soon after surgery in 1116 patients. Three hundred twenty (29%) patients showed a high NT-proBNP value and were enrolled: 108 were assigned to the metoprolol group, 102 to the losartan group, and 110 to the control group. Overall, the incidence of postoperative atrial fibrillation was 20% (n = 64); it was significantly lower in the metoprolol and losartan groups compared with the control group [6%, 12%, and 40%, respectively; relative risk 0.19, 95% confidence intervals (CIs), 0.09-0.37; P < 0.001 in the metoprolol group; and 0.29, 95% CI, 0.16-0.52; P < 0.001 in the losartan group). No significant difference was found when the metoprolol and losartan groups were directly compared (P = 0.21). A prophylactic treatment with metoprolol or losartan, initiated soon after lung cancer surgery in patients with high NT-proBNP levels, significantly reduced the occurrence of postoperative atrial fibrillation.Keywords
This publication has 48 references indexed in Scilit:
- Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgeryAmerican Heart Journal, 2012
- Postoperative Atrial FibrillationISRN Cardiology, 2011
- N-Terminal Pro-B-type Natriuretic Peptide Is Useful to Predict Cardiac Complications Following Lung Resection SurgeryThe Korean Journal of Thoracic and Cardiovascular Surgery, 2011
- Is a Pre-Operative Brain Natriuretic Peptide or N-Terminal Pro–B-Type Natriuretic Peptide Measurement an Independent Predictor of Adverse Cardiovascular Outcomes Within 30 Days of Noncardiac Surgery?JACC, 2009
- Increased Perioperative N-Terminal Pro-B-Type Natriuretic Peptide Levels Predict Atrial Fibrillation After Thoracic Surgery for Lung CancerCirculation, 2007
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2006
- Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)American Heart Journal, 2005
- Effects of ??-Blockers on Neurohormonal Activation in Patients with Congestive Heart FailureDrugs, 2000
- Early reduction of neurohumoral factors plays a key role in mediating the efficacy of β-blocker therapy for congestive heart failureAmerican Heart Journal, 1996
- Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.Heart, 1994